drug

Cognitive Enhancement Therapy

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
BEHAVIORAL
Pre-approval / investigational in the US
Developed by Beth Israel Deaconess Medical Center
4 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
BEHAVIORAL

Indications

Trials

4
Promoting Activity and Cognitive Enrichment in Schizophrenia (PACES)
NCT04143126—Active Not Recruiting
Comparative Effectiveness of CET vs. SST in SMI (Serious Mental Illness)
NCT04321759—Unknown
What the Nose Knows: Hedonic Capacity, Psychosocial Interventions and Outcomes in Schizophrenia
NCT05282186—Completed
Brain Imaging, Cognitive Enhancement and Early Schizophrenia
NCT01561859—Completed

KOLs & investigators

2
Matcheri S. Keshavan, MDKOL score 9
Russell K Schutt, PhD

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Beth Israel Deaconess Medical Center
company
trial
Promoting Activity and Cognitive Enrichment in Schizophrenia (PACES)
NA
trial
Comparative Effectiveness of CET vs. SST in SMI (Serious Mental Illness)
NA
trial
What the Nose Knows: Hedonic Capacity, Psychosocial Interventions and Outcomes in Schizophrenia
NA
trial
Brain Imaging, Cognitive Enhancement and Early Schizophrenia
NA
trial
indication
Schizophrenia
indication
Schizophrenia and Related Disorders
indication
Anosmia
indication
Schizophrenia
indication
KOL
Matcheri S. Keshavan, MD
KOL score 9
person
Russell K Schutt, PhD
KOL score —
person